• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

T1是一种免疫球蛋白超家族成员,在乳腺细胞的H-ras依赖性上皮肿瘤中表达。

T1, an immunoglobulin superfamily member, is expressed in H-ras-dependent epithelial tumours of mammary cells.

作者信息

Rössler U, Andres A C, Reichmann E, Schmahl W, Werenskiold A K

机构信息

Department of Cell Chemistry, GSF-Forschungszentrum für Umwelt und Gesundheit, Neuherberg, Germany.

出版信息

Oncogene. 1993 Mar;8(3):609-17.

PMID:8437844
Abstract

T1 is a glycosylated protein in the carcinoembryonic antigen (CEA) family of tumour marker molecules. It was originally identified by virtue of its transient induction after the expression of p21H-ras in NIH3T3 fibroblasts. Here we show that the T1 gene is activated in mammary adenocarcinomas of transgenic mice harbouring an H-ras transgene under the control of the mammary-specific whey acidic protein (WAP) promoter. By contrast, T1 mRNA was not, or only faintly, detectable in mammary carcinomas of transgenic mice bearing a WAP-myc transgene. Thus, T1 overexpression does not appear to be a general tumour-specific phenomenon. A dependence of T1 gene expression on the action of p21H-ras is suggested by the observation of T1 mRNA in nude mouse tumours generated from H-ras-transformed cultured mammary epithelial cells. Interestingly, activation of the T1 gene is also found during the maturation of the mammary gland (3-4 weeks after birth), whereas it is absent during its terminal differentiation in pregnancy and lactation. This expression pattern suggests a role for the secreted T1 glycoprotein in the phase of epithelial proliferation of the mammary gland. It appears that p21H-ras-induced transformation of mammary epithelial cells mimics the situation occurring in puberty. In both developmental stages the T1 glycoprotein might affect cell interactions of the proliferating epithelial cells with the surrounding stroma. It might thus promote ductal outgrowth in gland maturation as well as invasive growth of p21H-ras-transformed mammary epithelial cells.

摘要

T1是肿瘤标志物分子癌胚抗原(CEA)家族中的一种糖基化蛋白。它最初是通过在NIH3T3成纤维细胞中表达p21H-ras后其短暂诱导而被鉴定出来的。在这里我们表明,在乳腺特异性乳清酸性蛋白(WAP)启动子控制下携带H-ras转基因的转基因小鼠的乳腺腺癌中,T1基因被激活。相比之下,在携带WAP-myc转基因的转基因小鼠的乳腺癌中未检测到或仅微弱检测到T1 mRNA。因此,T1的过表达似乎不是一种普遍的肿瘤特异性现象。从H-ras转化的培养乳腺上皮细胞产生的裸鼠肿瘤中观察到T1 mRNA,这表明T1基因表达依赖于p21H-ras的作用。有趣的是,在乳腺成熟过程中(出生后3 - 4周)也发现了T1基因的激活,而在妊娠和哺乳期的终末分化过程中则不存在。这种表达模式表明分泌的T1糖蛋白在乳腺上皮增殖阶段发挥作用。似乎p21H-ras诱导的乳腺上皮细胞转化模拟了青春期发生的情况。在这两个发育阶段,T1糖蛋白可能影响增殖上皮细胞与周围基质的细胞相互作用。因此,它可能促进腺体成熟过程中的导管生长以及p21H-ras转化的乳腺上皮细胞的侵袭性生长。

相似文献

1
T1, an immunoglobulin superfamily member, is expressed in H-ras-dependent epithelial tumours of mammary cells.T1是一种免疫球蛋白超家族成员,在乳腺细胞的H-ras依赖性上皮肿瘤中表达。
Oncogene. 1993 Mar;8(3):609-17.
2
Expression of a truncated Int3 gene in developing secretory mammary epithelium specifically retards lobular differentiation resulting in tumorigenesis.截短的Int3基因在发育中的分泌性乳腺上皮中的表达特异性地延缓小叶分化,导致肿瘤发生。
Cancer Res. 1996 Apr 15;56(8):1775-85.
3
neu and ras initiate murine mammary tumors that share genetic markers generally absent in c-myc and int-2-initiated tumors.neu和ras引发的小鼠乳腺肿瘤具有一些遗传标记,而这些标记在由c-myc和int-2引发的肿瘤中通常不存在。
Oncogene. 1994 Dec;9(12):3417-26.
4
H-ras induced transformation of mammary epithelium is favoured by increased oncogene expression or by inhibition of mammary regression.H-ras诱导的乳腺上皮细胞转化,因癌基因表达增加或乳腺退化受抑制而更易发生。
Oncogene. 1991 May;6(5):771-9.
5
Osteopontin expression in mammary gland development and tumorigenesis.骨桥蛋白在乳腺发育和肿瘤发生中的表达。
Cell Growth Differ. 1997 Oct;8(10):1061-9.
6
Expression of a viral oncoprotein during mammary gland development alters cell fate and function: induction of p53-independent apoptosis is followed by impaired milk protein production in surviving cells.病毒癌蛋白在乳腺发育过程中的表达会改变细胞命运和功能:p53非依赖性凋亡的诱导之后,存活细胞中的乳蛋白产生受损。
Cell Growth Differ. 1996 Jan;7(1):3-11.
7
Hyperplasia and impaired involution in the mammary gland of transgenic mice expressing human FGF4.表达人FGF4的转基因小鼠乳腺中的增生和退化受损。
Oncogene. 2000 Dec 7;19(52):6007-14. doi: 10.1038/sj.onc.1204011.
8
NDF/heregulin induces persistence of terminal end buds and adenocarcinomas in the mammary glands of transgenic mice.NDF/神经调节蛋白诱导转基因小鼠乳腺中终末芽和腺癌的持续存在。
Oncogene. 1996 Apr 18;12(8):1781-8.
9
Ha-ras and v-raf oncogenes, but not int-2 and c-myc, interfere with the lactogenic hormone dependent activation of the mammary gland specific transcription factor.Ha-ras和v-raf癌基因,但不是int-2和c-myc,会干扰乳腺特异性转录因子的催乳激素依赖性激活。
Cell Growth Differ. 1993 Jan;4(1):9-15.
10
Regulatory function of whey acidic protein in the proliferation of mouse mammary epithelial cells in vivo and in vitro.乳清酸性蛋白在体内外对小鼠乳腺上皮细胞增殖的调节作用
Dev Biol. 2004 Oct 1;274(1):31-44. doi: 10.1016/j.ydbio.2004.04.040.

引用本文的文献

1
The essential role of single Ig IL-1 receptor-related molecule/Toll IL-1R8 in regulation of Th2 immune response.单个免疫球蛋白白细胞介素-1受体相关分子/Toll白细胞介素-1受体8在调节Th2免疫反应中的重要作用。
J Immunol. 2009 Mar 1;182(5):2601-9. doi: 10.4049/jimmunol.0802729.
2
The IL-33/ST2 pathway: therapeutic target and novel biomarker.白细胞介素-33/ST2通路:治疗靶点与新型生物标志物
Nat Rev Drug Discov. 2008 Oct;7(10):827-40. doi: 10.1038/nrd2660.
3
Inhibition of T1/ST2 during respiratory syncytial virus infection prevents T helper cell type 2 (Th2)- but not Th1-driven immunopathology.
呼吸道合胞病毒感染期间抑制T1/ST2可预防2型辅助性T细胞(Th2)介导而非Th1驱动的免疫病理反应。
J Exp Med. 2001 Apr 2;193(7):785-92. doi: 10.1084/jem.193.7.785.
4
The absence of interleukin 1 receptor-related T1/ST2 does not affect T helper cell type 2 development and its effector function.白细胞介素1受体相关分子T1/ST2的缺失不影响2型辅助性T细胞的发育及其效应功能。
J Exp Med. 1999 Nov 15;190(10):1541-8. doi: 10.1084/jem.190.10.1541.
5
GATA-Dependent expression of the interleukin-1 receptor-related T1 gene in mast cells.肥大细胞中白细胞介素-1受体相关T1基因的GATA依赖性表达。
Mol Cell Biol. 1998 Sep;18(9):5320-31. doi: 10.1128/MCB.18.9.5320.